Search research articles
Contact Us
Filters
Showing results (21-30 of 134) with videos related to
Page
of 14
Sort By:
BMC Health Services Research
|
October 10, 2025
What drives patient cost variability in psoriasis care: a single centre study
Erin Roman, Filip Roodhooft, Jo Lambert, et al.
Contact Dermatitis
|
January 8, 2013
Occupational contact allergy caused by pao ferro (Santos rosewood): a report of two cases
Michiel Bonny, Olivier Aerts, Julien Lambert, et al.
Dermatology and Therapy
|
October 4, 2024
Demographics, Disease Characteristics, and Time to Effective Treatment of Patients with Psoriasis in the Ghent PsoPlus Cohort of 2021
Evelyn Meulewaeter, Anke Eylenbosch, Evelien Verhaeghe, et al.
The Journal of Dermatological Treatment
|
June 26, 2015
Practical guidance on immunogenicity to biologic agents used in the treatment of psoriasis: What can be learnt from other diseases?
Jo Lambert, Alexander Nast, Frank O Nestle, et al.
Experimental Dermatology
|
February 3, 2016
Analysis of telomere length as predictive marker in psoriasis for comorbidities
Emma Coussens, Lynda Grine, Jessica Bostoen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 23, 2022
Blocking interleukin-17 in psoriasis: Real-world experience from the PsoPlus cohort
Lisa Schots, Rani Soenen, Brigitte Blanquart, et al.
Contact Dermatitis
|
August 17, 2013
Contact dermatitis caused by lovage (Levisticum officinalis) essential oil
Hilde Lapeere, Barbara Boone, Evelien Verhaeghe, et al.
BMJ Open
|
January 9, 2026
Understanding psoriasis care costs and the impact of comorbidities: a time-driven activity-based costing analysis in an integrated practice unit
Joke Borzée, Brecht Cardoen, Filip Roodhooft, et al.
JAMA Dermatology
|
August 31, 2022
Credibility and Generalization of the Minimally Important Difference Concept in Dermatology: A Scoping Review
Reinhart Speeckaert, Arno Belpaire, Sandrine Herbelet, et al.
Expert Opinion on Drug Delivery
|
March 31, 2011
Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations
Mireille Van Gele, Barbara Geusens, Lieve Brochez, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 134) with videos related to
Sort By:
Page
of 14
BMC Health Services Research
|
October 10, 2025
What drives patient cost variability in psoriasis care: a single centre study
Erin Roman, Filip Roodhooft, Jo Lambert, et al.
Contact Dermatitis
|
January 8, 2013
Occupational contact allergy caused by pao ferro (Santos rosewood): a report of two cases
Michiel Bonny, Olivier Aerts, Julien Lambert, et al.
Dermatology and Therapy
|
October 4, 2024
Demographics, Disease Characteristics, and Time to Effective Treatment of Patients with Psoriasis in the Ghent PsoPlus Cohort of 2021
Evelyn Meulewaeter, Anke Eylenbosch, Evelien Verhaeghe, et al.
The Journal of Dermatological Treatment
|
June 26, 2015
Practical guidance on immunogenicity to biologic agents used in the treatment of psoriasis: What can be learnt from other diseases?
Jo Lambert, Alexander Nast, Frank O Nestle, et al.
Experimental Dermatology
|
February 3, 2016
Analysis of telomere length as predictive marker in psoriasis for comorbidities
Emma Coussens, Lynda Grine, Jessica Bostoen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 23, 2022
Blocking interleukin-17 in psoriasis: Real-world experience from the PsoPlus cohort
Lisa Schots, Rani Soenen, Brigitte Blanquart, et al.
Contact Dermatitis
|
August 17, 2013
Contact dermatitis caused by lovage (Levisticum officinalis) essential oil
Hilde Lapeere, Barbara Boone, Evelien Verhaeghe, et al.
BMJ Open
|
January 9, 2026
Understanding psoriasis care costs and the impact of comorbidities: a time-driven activity-based costing analysis in an integrated practice unit
Joke Borzée, Brecht Cardoen, Filip Roodhooft, et al.
JAMA Dermatology
|
August 31, 2022
Credibility and Generalization of the Minimally Important Difference Concept in Dermatology: A Scoping Review
Reinhart Speeckaert, Arno Belpaire, Sandrine Herbelet, et al.
Expert Opinion on Drug Delivery
|
March 31, 2011
Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations
Mireille Van Gele, Barbara Geusens, Lieve Brochez, et al.
Page
of 14